What is the Seq ID No for blinatumomab’s patent amino-acid sequence?
Blinatumomab is a specific biologic with sequence details typically referenced in patents using an internal “SEQ ID NO” identifier. However, the exact Seq ID No number depends on the specific patent document and claim set you mean (different patents—process, composition, use, or specific constructs—often use different SEQ ID NO entries).
To give you the correct “Seq ID No” for the blinatumomab amino-acid sequence, you need one of the following:
- the patent number (e.g., US…, EP…, WO…)
- the application/publication number (e.g., WO20xx…)
- a link or the title of the patent
- the list of SEQ ID NO entries shown in the document (or a screenshot/paste of the table)
Which patent should I look at (examples of why Seq ID NO changes)?
Blinatumomab-related patents can contain multiple sequences, such as:
- the variable regions (VH/VL) and their linkers
- full-length fusion/construct sequences
- individual chains (heavy/light or scFv components)
- engineered modifications (e.g., for stability or manufacturability)
- process-related sequence listings (for expression systems)
That means the “Seq ID No” you want will differ across documents and even within a single document depending on which part of the construct the patent calls “the amino-acid sequence.”
If you share the patent text, I can extract the Seq ID No precisely
Paste the sequence listing table (or the paragraph where it says “amino acid sequence” and references “SEQ ID NO”), and I’ll reply with:
- the exact Seq ID No number
- which region/construct that sequence corresponds to (full molecule vs domain vs chain)
- the exact amino-acid sequence shown under that SEQ ID NO
Quick way to proceed
Send either:
1) the patent publication number/link, or
2) the SEQ ID NO table rows from the patent listing.
Then I’ll identify the blinatumomab amino-acid sequence Seq ID No you’re asking for.
Sources: none provided.